The Florida Medical Cannabis Market Is Melting – New Cannabis Ventures

Each week, Florida’s Office of Medical Marijuana Use (OMMU), which is part of the state’s Department of Health, releases data on the state’s medical cannabis program, including an active patient count, a qualified physician count, new dispensary approvals and an update for each operator. That data includes the number of dispensaries and the unit sales each week. This is the eighth New Cannabis Ventures article in what will likely be monthly updates. We also published a newsletter about the state in May, suggesting that readers be careful with Florida. This article is based upon the update that was provided this week by the state. Readers who are interested in the data going forward can visit the OMMU update page.

Patient Growth Is Slowing

We last updated on the Florida market a little over a month ago, and the annual growth in patient count had fallen to 3.9% in early October  from 8.4% in late May.  The rate has dropped to a new record low of 2.7% this past week:

While the number of patients is still increasing, the growth is very low. 882K patients represent 4% of the state’s population. The number of patients has actually slipped recently:

The post-pandemic population boom aided patient growth, and some program improvements have helped excite Florida residents. There has been an increase in dispensaries to 692 from 602 a year ago. This is an increase of 15.0%, which is much faster than the medical cannabis patient growth has been at 3.1%.

Unit Growth Remains Strong

We recently shared that Florida revenue was up only 1.4% from a year earlier in April by the estimate of BDSA. This was a record low. Florida’s growth picked up a bit afterwards, but in October, it rose only 3.6%. This is quite slow, especially considering patient growth and dispensary growth.

The increased competition and falling prices combined with slightly increasing sales has suggested that unit growth remains strong. In the most recent week, sales of medical cannabis product units with THC soared by 36.3% from a year ago. A month ago, it grew 12.6% from a year ago, so this was a major change. Smokeable flower units expanded 22.5% from the week ending 11/09/23.

Conclusion

We warned readers on May 17th regarding the MSOs that are big in Florida, as investors seemed overly optimistic. The entire cannabis market has pulled back since then, and the entire group of MSOs is sharply lower, especially after the defeat of the adult-use ballot initiative last week. Three of the four leaders in Florida have declined substantially though 11/11:

The overall market, as measured by the NCV Global Cannabis Stock Index, has declined by 34.6% since then as of 11/11, and the NCV American Cannabis Operator Index has dropped 55.8%. Three of the Florida 4 have dropped by more than both of the

Investors  likely will not be happy with a mature medical market that is slowing and  becoming more competitive. Investors should remain careful in our view with the big Florida operators, though Verano Holdings, which is down the most, has less exposure than Ayr Wellness and Trulieve. I have bought VRNOF in my model portfolio at 420 Investor on this big decline.

Based in Houston, Alan leverages his experience as founder of online community 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email